SEC
Filing

SEC Filing Details

Document Details

Form
Filing Date
May 5, 2017
Document Date
May 5, 2017
Form Description
Notification filed by National Securities Exchange to report the removal from listing and registration on a national securities exchange
Filing Group
Other
Company
Altimmune
Issuer
ALTIMMUNE, INC.
 

Investor Contact

Richard Eisenstadt
Chief Financial Officer

Email: reisenstadt@altimmune.com

 

Email Alerts

Automatically receive Altimmune, Inc. financial information by e-mail

Subscribe